Search Results 1351-1360 of 17286 for Prenatal Pilgrimage

  1. Publications - Elise C. Carey, M.D. - Mayo Clinic

    Palliative Care, version 1.2025 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), nccn.org. 2025. Sanders JJ, Benotti E, Jaramillo C, ...

  2. Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension - Mayo Clinic

    If female: planned or known pregnancy, positive urine or serum pregnancy test, or lactating/breastfeeding; Previous treatment with emricasan or active ...

  3. Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA - Mayo Clinic

    There are two study questions we are asking in this randomized phase II/III trial based on a blood biomarker, Epstein Barr virus (EBV) deoxyribonucleic acid ( ...

  4. MC200404, Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

    NOTE: If the urine test is positive or cannot be confirmed as negative, a serum pregnancy test will be required. Women of childbearing potential must agree ...

  5. Mayo Clinic

    infographic-achdlifelongcare-app-desktop-960-rev · National Doctors' Day is March 30! · About Mayo Clinic · Medical Professionals · Businesses · Students.

  6. Dorsal spinal cord stimulation vs medical management for the treatment of low back pain - Mayo Clinic

    ... pregnancy during the clinical investigation follow-up period. Female subjects of child-bearing potential must have a negative pregnancy test done within 7 ...

  7. A Study Of Remote Voice Analysis Tool For Diagnosing And Monitoring ME/CFS - Mayo Clinic

    Pregnant individuals will be excluded at the enrollment stage of Aim 1 and Aim 2 of this study, as voice changes can occur during pregnancy as related to ...

  8. Publications - Anuradha Luke, M.D. - Mayo Clinic

    McCoy RG, Juntunen MB, Ridgeway JL, Hentz JG, Glasgow AE, Liedl C, Murley BM, Warrington CE, Sundt WJ, Krpata TS, Haugo OA, Lampman MA, Fink AL, ...

  9. Publications - Trish J. Simner, Ph.D. - Mayo Clinic

    Simner PJ. The shift from "MIC-Only" back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know ...

  10. A Study to Evaluate Pomalidomide to Treat Bleeding in Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

    Females of childbearing potential (FCBP)† must adhere to the pregnancy testing schedule mandated by the POMALYST REMS® program. Ability to understand and ...